Literature DB >> 18752568

Evaluation of the physiological significance of botrocetin/ von Willebrand factor in vitro signaling.

J Liu1, M Joglekar, J Ware, M E C Fitzgerald, C A Lowell, M C Berndt, T K Gartner.   

Abstract

BACKGROUND: A signaling pathway is difficult, if not impossible, to elucidate in platelets using only in vivo studies. Likewise, the physiological significance of signaling information obtained exclusively from in vitro observations is unknown. Therefore, both in vitro and in vivo experiments are required to establish the physiological significance of a signaling pathway.
OBJECTIVE: To evaluate the physiological significance of signaling data obtained from botrocetin (bt)/von Willebrand factor (VWF)-stimulated washed platelets.
METHOD: Stable thrombus formation in response to FeCl(3)-induced injury of the mouse carotid artery was used to evaluate the physiological significance of signaling data obtained from bt/VWF-stimulated washed platelets.
RESULTS: Syk, PLCgamma2, Galphaq and P2Y12, but not LAT, were found either to be required for or to affect stable thrombus formation. Prior in vitro studies had demonstrated that LAT is not required for bt/VWF-induced platelet aggregation in the presence of exogenous fibrinogen. These data provide the first demonstration of the in vivo role for these signaling molecules in GPIb-dependent/initiated signal transduction and are consistent with the signaling pathway deduced from in vitro studies of bt/VWF-stimulated washed platelets using metabolic inhibitors and knockout mice.
CONCLUSION: The broad agreement between the in vitro and the in vivo results establish that bt/VWF stimulation of washed platelets can provide physiologically significant glycoprotein Ib-dependent/initiated signaling data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752568      PMCID: PMC2982674          DOI: 10.1111/j.1538-7836.2008.03135.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  38 in total

1.  Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin alpha(2)beta(1).

Authors:  S M Jung; M Moroi
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

2.  Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors.

Authors:  D Wang; J Feng; R Wen; J C Marine; M Y Sangster; E Parganas; A Hoffmeyer; C W Jackson; J L Cleveland; P J Murray; J N Ihle
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 4.  The expanding role for ITAM-based signaling pathways in immune cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Sci STKE       Date:  2007-03-13

Review 5.  Signaling and regulation of the platelet glycoprotein Ib-IX-V complex.

Authors:  Xiaoping Du
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

6.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

Authors:  C J Foster; D M Prosser; J M Agans; Y Zhai; M D Smith; J E Lachowicz; F L Zhang; E Gustafson; F J Monsma; M T Wiekowski; S J Abbondanzo; D N Cook; M L Bayne; S A Lira; M S Chintala
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

7.  Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo.

Authors:  Junling Liu; Malinda E Fitzgerald; Michael C Berndt; Carl W Jackson; T Kent Gartner
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

8.  Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.

Authors:  Christophe Dubois; Laurence Panicot-Dubois; Justin F Gainor; Barbara C Furie; Bruce Furie
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

9.  Hematopoietic lineage cell specific protein 1 (HS1) is a functionally important signaling molecule in platelet activation.

Authors:  Bryan N Kahner; Robert T Dorsam; Sripal R Mada; Soochong Kim; Timothy J Stalker; Lawrence F Brass; James L Daniel; Daisuke Kitamura; Satya P Kunapuli
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

10.  The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.

Authors:  Wolfgang Bergmeier; Crystal L Piffath; Tobias Goerge; Stephen M Cifuni; Zaverio M Ruggeri; Jerry Ware; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

View more
  7 in total

1.  Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.

Authors:  M V Joglekar; Jerry Ware; Jin Xu; Malinda E C Fitzgerald; Theodore Kent Gartner
Journal:  Platelets       Date:  2012-06-21       Impact factor: 3.862

2.  Critical role for Syk in responses to vascular injury.

Authors:  Patrick Andre; Toshifumi Morooka; Derek Sim; Keith Abe; Clifford Lowell; Nisha Nanda; Suzanne Delaney; Gail Siu; Yibing Yan; Stan Hollenbach; Anjali Pandey; Huiyun Gao; Yunmei Wang; Kohsuke Nakajima; Sahil A Parikh; Can Shi; David Phillips; Whyte Owen; Uma Sinha; Daniel I Simon
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

3.  LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis.

Authors:  Brian Estevez; Aleksandra Stojanovic-Terpo; M Keegan Delaney; Kelly A O'Brien; Michael C Berndt; Changgeng Ruan; Xiaoping Du
Journal:  Blood       Date:  2013-04-25       Impact factor: 22.113

4.  Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs.

Authors:  Maan H Harbi; Christopher W Smith; Fawaz O Alenazy; Phillip L R Nicolson; Alok Tiwari; Steve P Watson; Mark R Thomas
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

5.  The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.

Authors:  Binggang Xiang; Guoying Zhang; Hongmei Ren; Manjula Sunkara; Andrew J Morris; T Kent Gartner; Susan S Smyth; Zhenyu Li
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

Review 6.  Structure and function of snake venom proteins affecting platelet plug formation.

Authors:  Taei Matsui; Jiharu Hamako; Koiti Titani
Journal:  Toxins (Basel)       Date:  2009-12-28       Impact factor: 4.546

7.  Integrin αIIb-mediated PI3K/Akt activation in platelets.

Authors:  Haixia Niu; Xue Chen; Ralph A Gruppo; Ding Li; Yanhua Wang; Lin Zhang; Kemin Wang; Weiran Chai; Yueping Sun; Zhongren Ding; T Kent Gartner; Junling Liu
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.